{"id":66314,"url":"https://lda.senate.gov/api/v1/clients/66314/?format=json","client_id":66314,"name":"CHROMADEX","general_description":"Niagen bioscience focusing on the potential of NAD+.","client_government_entity":null,"client_self_select":false,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-04-28","registrant":{"id":31758,"url":"https://lda.senate.gov/api/v1/registrants/31758/?format=json","house_registrant_id":33755,"name":"POLICY IMPACT COMMUNICATIONS, INC.","description":"Consulting firm","address_1":"444 North Capitol Street, NW","address_2":"Suite 840","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"WILLIAM NIXON","contact_telephone":"+1 202-641-2882","dt_updated":"2026-03-12T23:19:49.965782-04:00"}}